Tag: COVID-19

Pfizer gets PAXLOVID FDA approval for COVID-19 in high-risk adults

businessnewstoday- May 25, 2023

Pfizer has obtained approval for PAXLOVID, an oral combination therapy of nirmatrelvir tablets and ritonavir tablets, from the US Food and Drug Administration (FDA) to ... Read More

Everest Medicines commissions mRNA vaccine production plant in Jiashan

Raghuram Kadari- January 2, 2023

Everest Medicines, a China-based biopharmaceutical company, has commenced operations at its mRNA vaccine production plant in Jiashan, Zhejiang Province, thereby becoming a fully-integrated biopharma. With ... Read More

FDA grants EUA for Omicron-adapted Covid-19 vaccine for children below five

Raghuram Kadari- December 9, 2022

Pfizer and BioNTech have received the US Food and Drug Administration (FDA) emergency use authorization (EUA) for their Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine for children ... Read More

Peregrino phase 2 project : Equinor starts production from phase 2 of offshore Brazilian field

BNT Reporter- October 14, 2022

Peregrino phase 2 project : Oil and gas company Equinor has started oil production from the phase 2 development of the Peregrino oil field in ... Read More

Visby Medical adds $35m to Series E round for PCR diagnostic technology

businessnewstoday- July 2, 2022

Visby Medical, an American medical diagnostic company, has raised an additional $35 million for its PCR diagnostic technology to take its Series E funding round ... Read More

TCS roped in by QIAGEN to drive cloud transformation journey

businessnewstoday- June 16, 2022

Tata Consultancy Services (TCS) has been roped in by QIAGEN, a Germany-based provider of sample to insights solutions in life sciences and molecular diagnostics, for ... Read More

Infosys roped in by Backcountry to create and secure digital experience

businessnewstoday- May 23, 2022

Infosys has been roped in by Backcountry, an American online retailer of outdoor gear and apparel, to help in delivering a seamless and secure digital ... Read More

AstraZeneca strikes licensing deal with RQ Bio for SARS-CoV-2 targeting mAbs

- May 18, 2022

AstraZeneca has signed a licensing deal with RQ Biotechnology (RQ Bio) to gain access to a portfolio of early-stage monoclonal antibodies (mAbs) targeted against Covid-19 ... Read More

Gufic Biosciences gets DCGI nod for Thymosin Alpha-1 in Covid-19

- April 5, 2022

Gufic Biosciences has secured approval from the Drugs Controller General of India (DCGI) for Thymosin Alpha-1 (Immunocin α) as an add-on therapy for the treatment ... Read More

AstraZeneca gets UK MHRA approval for Evusheld for Covid-19 prevention

- March 18, 2022

AstraZeneca said that its antibody combination Evusheld (tixagevimab co-packaged with cilgavimab) has been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ... Read More